Alpha-cardiac actin (ACTC1) Mutation Analysis
ACTC1 gene that encodes cardiac muscle alpha actin is located in the long (q) arm of chromosme 15 at position 14. Cardiac α-actin, 42-kDa protein composed of 377 amino acids are responsible for muscle contraction and generation of force to support the pumping function of the heart. It is a fundamental structural protein necessary for the maintenance of myofibrillar integrity by forming thin filaments with tropomyosin and three troponins (C, I, and T). It extends from a complex mesh with cardiac alpha-actinin (ACTN2) at Z-lines towards the center of the sarcomere. Actins are highly conserved proteins; the alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Cardiac (ACTC1) and skeletal (ACTC1) alpha actins differ in four amino acids (Asp4Glu, Glu5Asp, Leu301Met, Ser360Thr; cardiac/skeletal).
Mutations in the cardiac actin gene (ACTC) have been implicated in the development of hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM). The α-cardiac actin gene ACTC was the first gene identified to harbor both HCM and DCM causing mutations. Mostly, missense mutations affect amino acid residues lying in close proximity to the myosin-binding region effect actin interaction with myosin. These mutant actin residues likely promote HCM by their effect on sarcomeric force generation.
HCM is an autosomal dominant genetic heart disorder characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. Pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels. The majority of HCM patients are asymptomatic. Only about 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intra-familial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. HCM is the most common cause of sudden cardiac death in young people with the prevalence of 1:500 in the general adult population.
The majority of the mutations in HCM are missense, insertion/deletion and frame-shift mutations. Mutations in ACTC1 account for < 3% of patients with HCM. Dilated cardiomyopathy (DCM) is most commonly inherited in an autosomal dominant or X-linked manner. DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. DCM is the most common cause of congestive heart failure in young patients, although, cardiac arrythmias, syncope and sudden death may also occur. It has a prevalence of approximately 1 per 2,500 in the adult population. Many people with dilated cardiomyopathy have no or only minor symptoms and live a normal life. Other individuals with DCM may develop symptoms such as fatigue, weight loss, fainting, palpitations, chest pain and sudden death. DCM can be categorized as acquired, syndromic, or non-syndromic. Mutations in ACTC1 account for <1% of patients with DCM. Some missense mutation in ACTC1 gene can also cause familial restrictive cardiomyopathy, left ventricular noncompaction, and atrial septal defect. This test is mostly used as part of the gene panel used for diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy.
- As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy
- Carrier screening for relatives and those with the family history
- Mutation or pathogenic variant in ACTC1 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants
- Any of the pathogenic variations detected it most likely will indicate familial hypertrophic cardiomyopathy and dilated cardiomyopathy
Negative for mutations analyzed (No mutation or pathogenic variant detected)
Whole blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- J Hum Genet. 2016;61: 41-50. [PMID: 26178429]
- BMC Med Genet. 2014;15: 99. [PMID: 25224718]
- Cytogenet Genome Res. 2019;157(3):148-152. [PMID: 30630173]
- J Card Fail. 2012; 18: 296-303. [PMID: 22464770]
- J Am Coll Cardiol. 2010;55: 1127-35. [PMID: 20022194]
- FEBS J. 2005;272: 2037-49. [PMID: 15819894]